Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia

Cancer - United States
doi 10.1002/cncr.25656
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Multiinstitution Retrospective Review of Long Term Outcomes in Pediatric Chronic Myeloid Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
OncologyHematology
2011English

Long-Term Safety and Efficacy of Dasatinib in the Treatment of Chronic-Phase Chronic Myeloid Leukemia Patients Resistant or Intolerant to Imatinib

Blood and Lymphatic Cancer: Targets and Therapy
2014English

Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) With Nilotinib as the Second-Line Treatment in Russian Federation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

The Role of Bosutinib in the Treatment of Chronic Myeloid Leukemia

Future Oncology
MedicineCancer ResearchOncology
2020English

Short Overview on the Current Treatment of Chronic Myeloid Leukemia in Chronic Phase

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Use of Second- And Third-Generation Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia: An Evolving Treatment Paradigm

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Second Malignancy After Treatment of Childhood Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy